North America DNA Diagnostics Market (2016-2022)
DNA diagnostics is relatively a mature market; therefore, the diagnostic technique and tools have been widely adopted in various applications such as infectious diseases, oncology, myogenic disorders, prenatal diagnostics, pre-implantation diagnostics and clinical diagnostic confirmation. The growing incidences of cancer around the world has driven the oncology market globally. The oncology segment of North America DNA Diagnostics Market is expected to grow at a CAGR of 11.6% during the forecast period.
Growing awareness about healthcare, and the need for cost effective diagnostic solutions & accurate & faster test results in the fast growing economies have contributed to the growth of the market. Additionally, rising incidences of chronic and infectious diseases, demand for automated instruments and growing governments’ expenditures for providing healthcare facilities are also contributing to the growth of the DNA diagnostics market. Lack of reimbursement policies and high priced products are some of the factors that restrict the market growth.
The report highlights the adoption of DNA Diagnostics in North America. Based on the Product Types, the North America DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The countries included in the report are U.S, Canada, Mexico and Rest of North America.
Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.
Growing awareness about healthcare, and the need for cost effective diagnostic solutions & accurate & faster test results in the fast growing economies have contributed to the growth of the market. Additionally, rising incidences of chronic and infectious diseases, demand for automated instruments and growing governments’ expenditures for providing healthcare facilities are also contributing to the growth of the DNA diagnostics market. Lack of reimbursement policies and high priced products are some of the factors that restrict the market growth.
The report highlights the adoption of DNA Diagnostics in North America. Based on the Product Types, the North America DNA Diagnostics Market is segmented into Instruments, Reagents and Service & software segment. Based on the Application, the market is bifurcated into Oncology, Infectious disease testing, Myogenic disorder diagnosis, Clinical confirmation diagnostics, Prenatal diagnosis, Pre-implantation diagnostics and other segments. Based on the Technology, the market is bifurcated into PCR, Microarrays, In situ hybridization, Sequencing Technology, Mass Spectrometry and other segments. Further, the market is segmented into POC (Point-of-Care), Central Laboratories and Self-Testing segments based on the End Users. The countries included in the report are U.S, Canada, Mexico and Rest of North America.
Key Players profiled in the report includes Sysmex Corporation, Bayer Corporation, Roche Diagnostics, Abbott Laboratories, Cepheid Inc, Hologic Corporation, Illumina, Novartis International Ag, Thermo Fisher Scientific Inc. and Bio-Rad Laboratories.
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America DNA Diagnostics Market, by Product Type
1.4.2 North America DNA Diagnostics Market, by Application
1.4.3 North America DNA Diagnostics Market, by Technology
1.4.4 North America DNA Diagnostics Market, by End User
1.4.5 North America DNA Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.3 Opportunities
2.4 North America DNA Diagnostics Market
2.4.1 North America DNA Diagnostics Market - By Country
2.4.2 North America DNA Diagnostics Market - By Product Types
2.4.3 North America DNA Diagnostics Market - By Application
2.4.4 North America DNA Diagnostics Market - By Technology
2.4.5 North America DNA Diagnostics Market - By End Users
CHAPTER 3. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES
3.1 North America DNA Diagnostics Instruments Market - By Country
3.2 North America DNA Diagnostics Reagents Market - By Country
3.3 North America DNA Diagnostics Service & software Market - By Country
CHAPTER 4. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION
4.1 North America Oncology DNA Diagnostics Market - By Country
4.2 North America Infectious Disease Testing DNA Diagnostics Market - By Country
4.3 North America Myogenic Disorder Diagnosis Market - By Country
4.4 North America Clinical Confirmation Diagnostics Market - By Country
4.5 North America Prenatal Diagnosis Market - By Country
4.6 North America Pre-implantation diagnostics Market - By Country
4.7 North America Others DNA Diagnostics Market - By Country
CHAPTER 5. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY
5.1 North America PCR DNA Diagnostics Market - By Country
5.2 North America Microarrays DNA Diagnostics Market - By Country
5.3 North America In situ hybridization DNA Diagnostics Market - By Country
5.4 North America Sequencing Technology DNA Diagnostics Market - By Country
5.5 North America Mass Spectrometry DNA Diagnostics Market - By Country
5.6 North America Other DNA Diagnostics Market - By Country
CHAPTER 6. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS
6.1 North America POC DNA Diagnostics Market - By Country
6.2 North America Central Laboratories DNA Diagnostics Market - By Country
6.3 North America Self-Testing DNA Diagnostics Market - By Country
CHAPTER 7. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY
7.1 U.S DNA Diagnostics Market
7.1.1 U.S DNA Diagnostics Market - By Product Types
7.1.2 U.S DNA Diagnostics Market - By Application
7.1.3 U.S DNA Diagnostics Market - By Technology
7.1.4 U.S DNA Diagnostics Market - By End Users
7.2 Canada DNA Diagnostics Market
7.2.1 Canada DNA Diagnostics Market - By Product Types
7.2.2 Canada DNA Diagnostics Market - By Application
7.2.3 Canada DNA Diagnostics Market - By Technology
7.2.4 Canada DNA Diagnostics Market - By End Users
7.3 Mexico DNA Diagnostics Market
7.3.1 Mexico DNA Diagnostics Market - By Product Types
7.3.2 Mexico DNA Diagnostics Market - By Application
7.3.3 Mexico DNA Diagnostics Market - By Technology
7.3.4 Mexico DNA Diagnostics Market - By End Users
7.4 Rest of North America DNA Diagnostics Market
7.4.1 Rest of North America DNA Diagnostics Market - By Product Types
7.4.2 Rest of North America DNA Diagnostics Market - By Application
7.4.3 Rest of North America DNA Diagnostics Market - By Technology
7.4.4 Rest of North America DNA Diagnostics Market - By End Users
CHAPTER 8. COMPANY PROFILE
8.1 Sysmex Corporation.
8.1.1 Company Overview
8.2 Bayer Corporation.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Analysis
8.3 Roche Diagnostics
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Analysis
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development
8.5 Cepheid Inc.
8.5.1 Company Overview
8.6 Hologic Corporation.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Analysis
8.8 Novartis International AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development
8.9 Thermo Fisher Scientific Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Analysis
8.1 Bio-Rad Laboratories.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development
?
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America DNA Diagnostics Market, by Product Type
1.4.2 North America DNA Diagnostics Market, by Application
1.4.3 North America DNA Diagnostics Market, by Technology
1.4.4 North America DNA Diagnostics Market, by End User
1.4.5 North America DNA Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.2.1 Drivers
2.2.2 Restraints
2.3 Opportunities
2.4 North America DNA Diagnostics Market
2.4.1 North America DNA Diagnostics Market - By Country
2.4.2 North America DNA Diagnostics Market - By Product Types
2.4.3 North America DNA Diagnostics Market - By Application
2.4.4 North America DNA Diagnostics Market - By Technology
2.4.5 North America DNA Diagnostics Market - By End Users
CHAPTER 3. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES
3.1 North America DNA Diagnostics Instruments Market - By Country
3.2 North America DNA Diagnostics Reagents Market - By Country
3.3 North America DNA Diagnostics Service & software Market - By Country
CHAPTER 4. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION
4.1 North America Oncology DNA Diagnostics Market - By Country
4.2 North America Infectious Disease Testing DNA Diagnostics Market - By Country
4.3 North America Myogenic Disorder Diagnosis Market - By Country
4.4 North America Clinical Confirmation Diagnostics Market - By Country
4.5 North America Prenatal Diagnosis Market - By Country
4.6 North America Pre-implantation diagnostics Market - By Country
4.7 North America Others DNA Diagnostics Market - By Country
CHAPTER 5. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY
5.1 North America PCR DNA Diagnostics Market - By Country
5.2 North America Microarrays DNA Diagnostics Market - By Country
5.3 North America In situ hybridization DNA Diagnostics Market - By Country
5.4 North America Sequencing Technology DNA Diagnostics Market - By Country
5.5 North America Mass Spectrometry DNA Diagnostics Market - By Country
5.6 North America Other DNA Diagnostics Market - By Country
CHAPTER 6. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS
6.1 North America POC DNA Diagnostics Market - By Country
6.2 North America Central Laboratories DNA Diagnostics Market - By Country
6.3 North America Self-Testing DNA Diagnostics Market - By Country
CHAPTER 7. NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY
7.1 U.S DNA Diagnostics Market
7.1.1 U.S DNA Diagnostics Market - By Product Types
7.1.2 U.S DNA Diagnostics Market - By Application
7.1.3 U.S DNA Diagnostics Market - By Technology
7.1.4 U.S DNA Diagnostics Market - By End Users
7.2 Canada DNA Diagnostics Market
7.2.1 Canada DNA Diagnostics Market - By Product Types
7.2.2 Canada DNA Diagnostics Market - By Application
7.2.3 Canada DNA Diagnostics Market - By Technology
7.2.4 Canada DNA Diagnostics Market - By End Users
7.3 Mexico DNA Diagnostics Market
7.3.1 Mexico DNA Diagnostics Market - By Product Types
7.3.2 Mexico DNA Diagnostics Market - By Application
7.3.3 Mexico DNA Diagnostics Market - By Technology
7.3.4 Mexico DNA Diagnostics Market - By End Users
7.4 Rest of North America DNA Diagnostics Market
7.4.1 Rest of North America DNA Diagnostics Market - By Product Types
7.4.2 Rest of North America DNA Diagnostics Market - By Application
7.4.3 Rest of North America DNA Diagnostics Market - By Technology
7.4.4 Rest of North America DNA Diagnostics Market - By End Users
CHAPTER 8. COMPANY PROFILE
8.1 Sysmex Corporation.
8.1.1 Company Overview
8.2 Bayer Corporation.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Analysis
8.3 Roche Diagnostics
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Research & Development Analysis
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development
8.5 Cepheid Inc.
8.5.1 Company Overview
8.6 Hologic Corporation.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development
8.7 Illumina, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Analysis
8.8 Novartis International AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development
8.9 Thermo Fisher Scientific Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Analysis
8.1 Bio-Rad Laboratories.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental Analysis
8.10.4 Research & Development
?
LIST OF TABLES
TABLE 1 NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 2 NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 3 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 4 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 5 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 6 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 7 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 8 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 9 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 10 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 11 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 12 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 13 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 14 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 15 NORTH AMERICA DNA DIAGNOSTICS INSTRUMENTS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 16 NORTH AMERICA DNA DIAGNOSTICS INSTRUMENTS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 17 NORTH AMERICA DNA DIAGNOSTICS REAGENTS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 NORTH AMERICA DNA DIAGNOSTICS REAGENTS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 NORTH AMERICA DNA DIAGNOSTICS SERVICE & SOFTWARE MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 NORTH AMERICA DNA DIAGNOSTICS SERVICE & SOFTWARE MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 22 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 23 NORTH AMERICA ONCOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 NORTH AMERICA ONCOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 NORTH AMERICA INFECTIOUS DISEASE TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 26 NORTH AMERICA INFECTIOUS DISEASE TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 27 NORTH AMERICA MYOGENIC DISORDER DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 28 NORTH AMERICA MYOGENIC DISORDER DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 29 NORTH AMERICA CLINICAL CONFIRMATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 30 NORTH AMERICA CLINICAL CONFIRMATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 31 NORTH AMERICA PRENATAL DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 32 NORTH AMERICA PRENATAL DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 33 NORTH AMERICA PRE-IMPLANTATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 34 NORTH AMERICA PRE-IMPLANTATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 35 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 36 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 37 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 38 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 39 NORTH AMERICA PCR DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 40 NORTH AMERICA PCR DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 41 NORTH AMERICA MICROARRAYS DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 42 NORTH AMERICA MICROARRAYS DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 43 NORTH AMERICA IN SITU HYBRIDIZATION DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 44 NORTH AMERICA IN SITU HYBRIDIZATION DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 45 NORTH AMERICA SEQUENCING TECHNOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 46 NORTH AMERICA SEQUENCING TECHNOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 47 NORTH AMERICA MASS SPECTROMETRY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 48 NORTH AMERICA MASS SPECTROMETRY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 49 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 50 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 51 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 52 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 53 NORTH AMERICA POC DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 54 NORTH AMERICA POC DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 55 NORTH AMERICA CENTRAL LABORATORIES DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 56 NORTH AMERICA CENTRAL LABORATORIES DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 57 NORTH AMERICA SELF-TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 58 NORTH AMERICA SELF-TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 59 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 60 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 61 U.S DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 62 U.S DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 63 U.S DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 64 U.S DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 65 U.S DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 66 U.S DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 67 U.S DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 68 U.S DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 69 U.S DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 70 U.S DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 71 CANADA DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 72 CANADA DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 73 CANADA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 74 CANADA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 75 CANADA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 76 CANADA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 77 CANADA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 78 CANADA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 79 CANADA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 80 CANADA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 81 MEXICO DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 82 MEXICO DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 83 MEXICO DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 84 MEXICO DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 85 MEXICO DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 86 MEXICO DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 87 MEXICO DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 88 MEXICO DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 89 MEXICO DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 90 MEXICO DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 91 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 92 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 93 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 94 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 95 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 96 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 97 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 98 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 99 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 100 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 101 KEY INFORMATION - SYSMEX CORPORATION.
TABLE 102 KEY INFORMATION - BAYER CORPORATION.
TABLE 103 KEY INFORMATION - ROCHE DIAGNOSTICS
TABLE 104 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 105 KEY INFORMATION - CEPHEID INC.
TABLE 106 KEY INFORMATION - HOLOGIC CORPORATION.
TABLE 107 KEY INFORMATION - ILLUMINA, INC.
TABLE 108 KEY INFORMATION - NOVARTIS INTERNATIONAL AG.
TABLE 109 KEY INFORMATION - THERMO FISHER SCIENTIFIC INC.
TABLE 110 KEY INFORMATION - BIO-RAD LABORATORIES.
TABLE 1 NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 2 NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 3 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 4 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 5 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 6 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 7 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 8 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 9 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 10 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 11 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 12 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 13 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 14 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 15 NORTH AMERICA DNA DIAGNOSTICS INSTRUMENTS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 16 NORTH AMERICA DNA DIAGNOSTICS INSTRUMENTS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 17 NORTH AMERICA DNA DIAGNOSTICS REAGENTS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 18 NORTH AMERICA DNA DIAGNOSTICS REAGENTS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 19 NORTH AMERICA DNA DIAGNOSTICS SERVICE & SOFTWARE MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 20 NORTH AMERICA DNA DIAGNOSTICS SERVICE & SOFTWARE MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 21 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 22 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 23 NORTH AMERICA ONCOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 24 NORTH AMERICA ONCOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 25 NORTH AMERICA INFECTIOUS DISEASE TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 26 NORTH AMERICA INFECTIOUS DISEASE TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 27 NORTH AMERICA MYOGENIC DISORDER DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 28 NORTH AMERICA MYOGENIC DISORDER DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 29 NORTH AMERICA CLINICAL CONFIRMATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 30 NORTH AMERICA CLINICAL CONFIRMATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 31 NORTH AMERICA PRENATAL DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 32 NORTH AMERICA PRENATAL DIAGNOSIS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 33 NORTH AMERICA PRE-IMPLANTATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 34 NORTH AMERICA PRE-IMPLANTATION DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 35 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 36 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 37 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 38 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 39 NORTH AMERICA PCR DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 40 NORTH AMERICA PCR DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 41 NORTH AMERICA MICROARRAYS DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 42 NORTH AMERICA MICROARRAYS DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 43 NORTH AMERICA IN SITU HYBRIDIZATION DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 44 NORTH AMERICA IN SITU HYBRIDIZATION DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 45 NORTH AMERICA SEQUENCING TECHNOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 46 NORTH AMERICA SEQUENCING TECHNOLOGY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 47 NORTH AMERICA MASS SPECTROMETRY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 48 NORTH AMERICA MASS SPECTROMETRY DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 49 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 50 NORTH AMERICA OTHER DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 51 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 52 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 53 NORTH AMERICA POC DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 54 NORTH AMERICA POC DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 55 NORTH AMERICA CENTRAL LABORATORIES DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 56 NORTH AMERICA CENTRAL LABORATORIES DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 57 NORTH AMERICA SELF-TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 58 NORTH AMERICA SELF-TESTING DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 59 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2012-2015
TABLE 60 NORTH AMERICA DNA DIAGNOSTICS MARKET - BY COUNTRY ($MILLION): 2016-2022
TABLE 61 U.S DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 62 U.S DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 63 U.S DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 64 U.S DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 65 U.S DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 66 U.S DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 67 U.S DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 68 U.S DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 69 U.S DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 70 U.S DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 71 CANADA DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 72 CANADA DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 73 CANADA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 74 CANADA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 75 CANADA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 76 CANADA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 77 CANADA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 78 CANADA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 79 CANADA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 80 CANADA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 81 MEXICO DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 82 MEXICO DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 83 MEXICO DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 84 MEXICO DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 85 MEXICO DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 86 MEXICO DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 87 MEXICO DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 88 MEXICO DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 89 MEXICO DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 90 MEXICO DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 91 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2012-2015
TABLE 92 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET ($MILLION): 2016-2022
TABLE 93 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2012-2015
TABLE 94 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY PRODUCT TYPES ($MILLION): 2016-2022
TABLE 95 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2012-2015
TABLE 96 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY APPLICATION ($MILLION): 2016-2022
TABLE 97 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2012-2015
TABLE 98 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY TECHNOLOGY ($MILLION): 2016-2022
TABLE 99 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2012-2015
TABLE 100 REST OF NORTH AMERICA DNA DIAGNOSTICS MARKET - BY END USERS ($MILLION): 2016-2022
TABLE 101 KEY INFORMATION - SYSMEX CORPORATION.
TABLE 102 KEY INFORMATION - BAYER CORPORATION.
TABLE 103 KEY INFORMATION - ROCHE DIAGNOSTICS
TABLE 104 KEY INFORMATION - ABBOTT LABORATORIES.
TABLE 105 KEY INFORMATION - CEPHEID INC.
TABLE 106 KEY INFORMATION - HOLOGIC CORPORATION.
TABLE 107 KEY INFORMATION - ILLUMINA, INC.
TABLE 108 KEY INFORMATION - NOVARTIS INTERNATIONAL AG.
TABLE 109 KEY INFORMATION - THERMO FISHER SCIENTIFIC INC.
TABLE 110 KEY INFORMATION - BIO-RAD LABORATORIES.
